Clinical trial
Sequential Treatment of Postmenopausal Women With Primary Osteoporosis…
NCT00365456 · Takeda, Industry · Completed
Key facts
| NCT number | NCT00365456 |
|---|---|
| Title | Sequential Treatment of Postmenopausal Women With Primary Osteoporosis (FP-001-IM) |
| Official title | An Open Label, International, Multi Centre, Parallel Group, Phase III b, Randomised Trial, Investigating Lumbar Spine Bone Mineral Density (BMD) Changes in Postmenopausal Women With Primary Osteoporosis Initially Treated With 12 Months of Full Length Parathyroid Hormone (PTH 1-84) Followed by 12… |
| Acronym | PEAK |
| Lead sponsor | Takeda, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoporosis |
| Intervention type | Drug |
| Interventions | Parathyroid Hormone (PTH), Risedronate |
| Enrollment | 407 |
| Start date | Jul 1, 2006 |
| Primary completion | Jan 1, 2011 |
| Completion | Aug 1, 2011 |
| First posted | Aug 17, 2006 |
| Last update posted | Aug 20, 2012 |
| Countries | Denmark |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: